Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1I2 | O75469 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Allo-Ocimene SCHEMBL9011362 | 0.91 | TSHR (0.56) | NR1I2LMNAPGRTSHR | |
| SCHEMBL21954156 | 0.82 | TSHR (0.48) | TSHR | |
| SCHEMBL2108765 | 0.82 | TSHR (0.48) | TSHR | |
| SCHEMBL111818 | 0.82 | TSHR (0.48) | TSHR | |
| SCHEMBL29587138 | 0.79 | TSHR (0.60) | NR1I2LMNAPGRTSHR | |
| Ocimene SCHEMBL8201861 | 0.77 | NR1I2 (0.37) | NR1I2LMNAPGRTSHR | |
| Allo-Ocimene SCHEMBL712009 | 0.75 | TSHR (0.34) | NR1I2LMNAPGRTSHR | |
| Ocimene SCHEMBL15011308 | 0.75 | TSHR (0.48) | NR1I2LMNAPGRTSHR | |
| SCHEMBL28429614 | 0.74 | NR1I2 (0.36) | NR1I2LMNAPGR | |
| SCHEMBL1270899 | 0.74 | KMT2A (0.46) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6121234-A | ORALLY COADMINISTERING TO MAMMAL PHARMACEUTICAL COMPOUND AND ESSENTIAL OIL | AVMAX, INC. (US) | 2000-09-19 | — | — | US | disclosed |
| US-5916566-A | Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds | AVMAX, INC. (US) | 1999-06-29 | — | — | US | disclosed |
| US-5716928-A | ADMINISTERING DRUG CONCURRENTLY WITH ESSENTIAL OIL | AVMAX, INC. (US) | 1998-02-10 | — | — | US | disclosed |
| US-5665386-A | Use of essential oils to increase bioavailability of oral pharmaceutical compounds | AVMAX, INC. (US) | 1997-09-09 | — | — | US | disclosed |